It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Several conventional cross-sectional studies have investigated the impact of the coronavirus disease (COVID-19) pandemic on patients with axial spondyloarthritis (axSpA) and reached contrary results regarding health and well-being. As analysis of web search data already provided insights into public interest and unmet needs, this study aimed to examine axSpA-related web searches before and during COVID-19 pandemic to gain a different perspective on the impact of COVID-19 on this disease. The Google Ads Keyword Planner was used to generate axSpA-related keywords and their monthly number of searches between June 2018 and November 2021 in Germany. These keywords were qualitatively classified into seven categories. A total of 538 axSpA-related keywords were used for the analysis. The number of axSpA-related searches increased during COVID-19 pandemic (before: n = 1,525,010 vs. during: n = 1,848,300), particularly searches for symptoms, disease outcomes, and causes, while interest in disease management and diagnosis decreased. This study demonstrated a shift in public interest in axSpA during COVID-19 in Germany and highlights an urgent expansion of telemedicine to be prepared for exceptional situations such as a pandemic.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Technical University of Munich, Department of Dermatology and Allergy, TUM School of Medicine and Health, Munich, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966)
2 Technical University of Munich, Department of Dermatology and Allergy, TUM School of Medicine and Health, Munich, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966); Pettenkofer School of Public Health, Munich, Germany (GRID:grid.6936.a); LMU Munich, Institute for Medical Information Processing, Biometry, and Epidemiology-IBE, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)
3 Medizinisches Versorgungszentrum für Rheumatologie Dr. M. Welcker GmbH, Planegg, Germany (GRID:grid.520060.1); RheumaDatenRhePort GbR, Planegg, Germany (GRID:grid.520060.1)
4 Technical University of Munich, Department of Dermatology and Allergy, TUM School of Medicine and Health, Munich, Germany (GRID:grid.6936.a) (ISNI:0000 0001 2322 2966); Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)